TherapeuticsMD, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TherapeuticsMD, Inc. on December 18, 2018. The report serves to disclose an investor presentation furnished as Exhibit 99.1, which was utilized for meetings with investors and analysts on the filing date and subsequently.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the existence of an investor presentation rather than a financial statement.
Material Changes
No material changes to financial performance or operations are detailed within the text of this specific filing. The report focuses solely on the dissemination of the attached investor presentation.
Guidance, Outlook, and Risks
The filing explicitly states that the information contained herein, including the attached presentation, is furnished pursuant to Item 7.01 (Regulation FD Disclosure). Consequently, this information is not deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. The text does not contain specific guidance, outlook, or risk factors within the body of the report itself.
Key Facts for Investor Verification
- Review Exhibit 99.1 (TherapeuticsMD, Inc. presentation dated December 2018) for actual financial data, strategic outlook, and management commentary.
- Note that the content of the presentation is not incorporated by reference into this filing unless expressly stated in a future filing.
- Verify the company's status as a Nevada corporation with principal executive offices in Boca Raton, FL.